EC endocrinology and metabolic research最新文献

筛选

英文中文

The Prevalence of Cardiovascular Disease and Other Comorbidities Among American Indian and Alaska Native Adults with Diabetes. 美国印第安人和阿拉斯加原住民成人糖尿病患者心血管疾病及其他并发症的患病率。

EC endocrinology and metabolic research Pub Date : 2021-02-01 Epub Date: 2021-01-27

Joan M O'Connell, Jennifer E Rockell, Judith C Ouellet, Sherri Yoder, Kimberly E Lind, Charlton Wilson, Andrew Friedson, Spero M Manson

{"title":"The Prevalence of Cardiovascular Disease and Other Comorbidities Among American Indian and Alaska Native Adults with Diabetes.","authors":"Joan M O'Connell, Jennifer E Rockell, Judith C Ouellet, Sherri Yoder, Kimberly E Lind, Charlton Wilson, Andrew Friedson, Spero M Manson","doi":"","DOIUrl":"","url":null,"abstract":"Aims: American Indians and Alaska Native (AI/ANs) peoples experience significant health disparities compared to the U.S. general population. We report comorbidities among AI/ANs with diabetes to guide efforts to improve their health status.Methods: Drawing upon data for over 640,000 AI/ANs who used services funded by the Indian Health Service, we identified 43,518 adults with diabetes in fiscal year 2010. We reported the prevalence of comorbidities by age and cardiovascular disease (CVD) status. Generalized linear models were estimated to describe associations between CVD and other comorbidities.Results: Nearly 15% of AI/AN adults had diabetes. Hypertension, CVD and kidney disease were comorbid in 77.9%, 31.6%, and 13.3%, respectively. Nearly 25% exhibited a mental health disorder; 5.7%, an alcohol or drug use disorder. Among AI/ANs with diabetes absent CVD, 46.9% had 2 or more other chronic conditions; the percentage among adults with diabetes and CVD was 75.5%. Hypertension and tobacco use disorders were associated with a 71% (95% CI for prevalence ratio: 1.63 - 1.80) and 33% (1.28 - 1.37) higher prevalence of CVD, respectively, compared to adults without these conditions.Conclusion: Detailed information on the morbidity burden of AI/ANs with diabetes may inform enhancements to strategies implemented to prevent and treat CVD and other comorbidities.","PeriodicalId":93429,"journal":{"name":"EC endocrinology and metabolic research","volume":"6 2","pages":"5-20"},"PeriodicalIF":0.0,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580367/pdf/nihms-1751606.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39702703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Endocrine Disrupting Chemicals, Transgenerational Epigenetics and Metabolic Diseases. 干扰内分泌的化学品、跨代表观遗传学和代谢疾病。

EC endocrinology and metabolic research Pub Date : 2017-11-01

Aliya Feroe, Richard Broene, David Albuquerque, Patricia Ruiz

引用次数: 0